Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC
Overview of attention for article published in Journal of Thoracic Oncology, June 2019
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (85th percentile)
-
Good Attention Score compared to outputs of the same age and source (66th percentile)
Mentioned by
- news
- 1 news outlet
- 1 X user
- 1 Redditor
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 90 Mendeley